Zoetis (ZTS) revenue: $9.5B
Zoetis reported $9.5B of revenue for the year ended Dec 31, 2025, up 2.3% from $9.3B a year earlier.
From Zoetis's filings with the SEC · Read the filing · ZTS stock page
Zoetis revenue by year
#448 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $9.5B | +2% |
| Dec 31, 2024 | $9.3B | +8% |
| Dec 31, 2023 | $8.5B | +6% |
| Dec 31, 2022 | $8.1B | +4% |
| Dec 31, 2021 | $7.8B | – |
Revenue of similar companies
Companies in the same industry as Zoetis, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Regeneron Pharmaceuticals | $14.3B | Dec 31, 2025 |
| Viatris | $14.3B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $12B | Dec 31, 2025 |
| Bausch Health Companies | $10.3B | Dec 31, 2025 |
| Zoetis | $9.5B | Dec 31, 2025 |
| Organon | $6.2B | Dec 31, 2025 |
| BeOne Medicines | $5.3B | Dec 31, 2025 |
Questions and answers
What is Zoetis's revenue?
Zoetis reported $9.5B of revenue for the year ended Dec 31, 2025, up 2.3% from $9.3B a year earlier.
Numbers as reported in Zoetis's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology